Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters










Database
Language
Publication year range
1.
J Am Vet Med Assoc ; 261(8): 1160-1165, 2023 08 01.
Article in English | MEDLINE | ID: mdl-36884379

ABSTRACT

OBJECTIVE: The aim of this study was to determine whether the pharmacokinetics of maropitant, administered SC as a commercially available maropitant-containing injectable product (Cerenia Injectable), differ when combined with lactated Ringer solution prior to administration. ANIMALS: We used 6 adult spayed female Beagle dogs between 3 and 6 years of age, with a mean weight of 9.58 kg. PROCEDURES: In this randomized crossover study, the dogs underwent 2 treatment protocols separated by a 14-day washout period: (1) an SC injection of 1 mg/kg of Cerenia Injectable (maropitant citrate; 10 mg/mL) and (2) 1 mg/kg of Cerenia Injectable diluted in 10 mL/kg of lactated Ringer injectable solution (LRS) given SC. Plasma maropitant concentrations were assessed by mass spectrometry. Pharmacokinetic analysis was performed using pharmacokinetic and pharmacodynamic data-analysis software to determine maximum plasma concentration (Cmax), time to reach maximum concentration, half-life, total exposure to the drug, mean residence time, clearance rate per fraction absorbed, and absorption and elimination kinetic parameters. RESULTS: Cmax was reduced by 26% (P = .002), the absorption rate constant decreased 80% (P = .031), and the absorption half-life increased when Cerenia was administered diluted in LRS. CLINICAL RELEVANCE: Administration of maropitant (Cerenia) diluted in LRS had a pharmacokinetic impact, resulting in a significantly reduced Cmax and slower absorption. Clinical efficacy was not assessed in this study.


Subject(s)
Quinuclidines , Animals , Female , Dogs , Pharmaceutical Preparations , Ringer's Lactate , Cross-Over Studies , Quinuclidines/therapeutic use
2.
Biofactors ; 44(5): 465-479, 2018 Sep.
Article in English | MEDLINE | ID: mdl-30171731

ABSTRACT

Hypertension is one of the silent killers in the world with high mortality and morbidity. The exposure of humans and animals to fluoride and/or fluoride containing compounds is almost inevitable. This study investigated the modulatory effects of quercetin on sodium fluoride (NaF)-induced hypertension and cardiovascular complications. Forty male rats were randomly separated into four groups (n =10). Group A animals served as the control, rats in Group B were exposed to 300 ppm of NaF, Groups C and D animals were exposed to 300 ppm of NaF along with quercetin orally at 50 mg/kg and 100 mg/kg orally by gavage, while NaF was administered in drinking water, respectively, for a week. Administration of NaF caused severe hypertension as indicated with significant increases in the systolic, diastolic, and mean arterial blood pressure, together with prolonged ventricular depolarization (QRS) and the time between the start of the Q wave and the end of the T wave in the heart's electrical cycle (QT) intervals when compared with controls. NaF significantly decreased the activities of antioxidant enzymes, caused increase in markers of oxidative stress and renal damage when compared with controls. Immunohistochemical staining revealed lower expressions of Hsp70, ERK, and PPARγ in the heart, kidney, and aorta of rats-administered NaF relative to the controls. Together, quercetin co-treatment with NaF restored blood pressure, normalized QRS interval, and improved antioxidant defense system. © 2018 BioFactors, 44(5):465-479, 2018.


Subject(s)
Hypertension/drug therapy , Lipid Peroxidation/drug effects , Oxidative Stress/drug effects , Quercetin/administration & dosage , Animals , Antioxidants/metabolism , Blood Pressure/drug effects , Glutathione/metabolism , HSP70 Heat-Shock Proteins/genetics , Humans , Hypertension/chemically induced , Hypertension/genetics , Hypertension/pathology , MAP Kinase Signaling System/drug effects , PPAR gamma/genetics , Rats , Rats, Wistar , Signal Transduction/drug effects , Sodium Fluoride/toxicity , Superoxide Dismutase/genetics
3.
J Diet Suppl ; 15(3): 269-284, 2018 May 04.
Article in English | MEDLINE | ID: mdl-28800275

ABSTRACT

Parquetina nigrescens is commonly used to treat diseases in humans and animals in developing countries, including Nigeria. This study evaluates the effects of its polyphenol-rich fraction (prf) on dichlorvos-induced cardio- and renal toxicity. There were several factors assessed during this study, including cardiac and renal markers, serum myeloperoxidase and xanthine oxidase, and electrocardiograph (ECG) changes. The changes in electrocardiograph (ECG) were recorded. Immunohistochemistry of cardiac and renal p38 and nitrotyrosine was determined. Dichlorvos exposure caused a significant decrease in L-glutathione (reduced glutathione) and other antioxidant enzymes with increases in malondialdehyde, myeloperoxidase, advanced oxidation protein products, and protein carbonyl levels. It also brought about alterations in microanatomy of the heart and kidneys accompanied by increases in serum creatinine and urea levels. Exposure to dichlorvos induced prolonged QRS interval and shortened QT durations in rats. Immunohistochemistry revealed lower expressions of cardiac nitrotyrosine and renal p38 (mitogen-activated protein kinase; MAPK) in rats treated with prf of P. nigrescens. Combining all, prf of P. nigrescens demonstrated antioxidant as well as protective properties in the heart and kidneys of rats exposed to dichlorvos. It ameliorated dichlorvos-induced cardio- and nephrotoxicity giving credence to its use in ethnomedicine.


Subject(s)
Cryptolepis/chemistry , Dietary Supplements , Organophosphate Poisoning/prevention & control , Plant Components, Aerial/chemistry , Plant Extracts/therapeutic use , Polyphenols/therapeutic use , Protective Agents/therapeutic use , Administration, Oral , Animals , Biomarkers/blood , Biomarkers/metabolism , Cryptolepis/growth & development , Dichlorvos/administration & dosage , Dichlorvos/antagonists & inhibitors , Dichlorvos/toxicity , Dietary Supplements/analysis , Heart Ventricles/drug effects , Heart Ventricles/metabolism , Heart Ventricles/pathology , Heart Ventricles/physiopathology , Insecticides/administration & dosage , Insecticides/antagonists & inhibitors , Insecticides/toxicity , Kidney/drug effects , Kidney/metabolism , Kidney/pathology , Kidney/physiopathology , Male , Nigeria , Organophosphate Poisoning/metabolism , Organophosphate Poisoning/pathology , Organophosphate Poisoning/physiopathology , Plant Components, Aerial/growth & development , Plant Extracts/administration & dosage , Plant Extracts/chemistry , Plant Extracts/isolation & purification , Polyphenols/administration & dosage , Polyphenols/analysis , Polyphenols/isolation & purification , Protective Agents/administration & dosage , Protective Agents/chemistry , Protective Agents/isolation & purification , Random Allocation , Rats, Wistar , Renal Insufficiency/etiology , Renal Insufficiency/prevention & control , Tyrosine/agonists , Tyrosine/analogs & derivatives , Tyrosine/antagonists & inhibitors , Tyrosine/metabolism , Ventricular Dysfunction/etiology , Ventricular Dysfunction/prevention & control , p38 Mitogen-Activated Protein Kinases/antagonists & inhibitors , p38 Mitogen-Activated Protein Kinases/chemistry , p38 Mitogen-Activated Protein Kinases/metabolism
4.
Redox Rep ; 22(6): 467-477, 2017 Nov.
Article in English | MEDLINE | ID: mdl-28366046

ABSTRACT

OBJECTIVES: Arsenic is a ubiquitous element that is widely distributed in the environment to which man and animals are exposed. Cardiovascular disease is one of the aftermaths of chronic arsenic exposure-related morbidity and mortality. This study sought to investigate the possibility of reversal from arsenic-induced cardio-renal toxicity following exposure and subsequent withdrawal. The study also seeks to understand the mechanism of action of this reversal. METHODS: Rats were orally exposed to sodium arsenite at 10, 20 and 40 mg/kg daily for 4 weeks followed by 4 weeks of withdrawal. RESULTS: Exposure to arsenic caused a significant increase in malondialdehyde, H2O2 generation but decrease total thiol and reduced glutathione levels in both cardiac and renal tissues. Furthermore, increases in superoxide dismutase, glutathione-S-transferase and catalase with significant increases in glutathione peroxidase activities were observed in the cardiac tissues. On the contrary, a significant reduction in the renal antioxidant enzyme activity was recorded following exposure. Also, antioxidant defense system did not return to apparent values after arsenic withdrawal. Immunohistochemistry revealed a reduction in the expression of the pro-survival protein-protein kinase B (Akt/PKB) following exposure to arsenic and this was not reversed by withdrawal Discussion: Exposure to arsenic caused cardio-renal toxicity via induction of oxidative stress and down-regulation of Akt/PKB expressions.


Subject(s)
Arsenites/toxicity , Kidney/metabolism , Oxidative Stress/drug effects , Proto-Oncogene Proteins c-akt/metabolism , Sodium Compounds/toxicity , Animals , Antioxidants/metabolism , Immunohistochemistry , Kidney/drug effects , Rats , Signal Transduction/drug effects
5.
J Ayurveda Integr Med ; 8(1): 27-36, 2017.
Article in English | MEDLINE | ID: mdl-28256303

ABSTRACT

BACKGROUND: Parquetina nigrescens (Afzel.) Bullock of the family Asclepiadaceae is known for its antioxidant effects with wide range of uses in Southwestern Nigeria especially in traditional medicine. This study was undertaken to explore if polyphenol-rich fraction (prf) from P. nigrescens will ameliorate dichlorvos-induced neurotoxicity and apoptosis. The exploration utilized evaluation of markers of oxidative stress, apoptosis and serum acetylcholinesterase (AchE) levels. METHODS: Forty Wistar rats randomly placed in four groups were utilized for the study. Animals in Group A received corn oil, group B- dichlorvos (16 mg/kg), groups C and D- dichlorvos + 100 and 200 mg/kg prf of P. nigrescens respectively. Markers of oxidative stress, antioxidants and apoptosis were assessed in the serum and brain tissues using biochemical assay and immunohistochemistry. RESULTS: Exposure to dichlorvos caused significant decreases in AchE, catalase, superoxide dismutase, glutathione peroxidase (GPx) and increases in hydrogen peroxide (H2O2) generation and malondialdehyde levels. Histopathology and immunohistochemistry of the cerebellum and cerebrum of rats exposed to dichlorvos revealed greater neurotoxic effects in the cerebellum as well as decreased expressions of AchE with a concomitant increase in Bax (proapototic) compared to prf of P. nigrescens treated rats. CONCLUSION: This study showed that dichlorvos caused cellular and tissue neurotoxicity by inhibiting AchE activity, induced oxidative stress and apoptosis in rats with prominent effects on the cerebellum than cerebrum. The prf of P. nigrescens showed amelioration of neurotoxicity by its antioxidative and antiapoptotic properties in rats exposed to dichlorvos.

SELECTION OF CITATIONS
SEARCH DETAIL
...